Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention
{{output}}
Myeloma bone disease (MBD) is the most visible aspect of plasma cell myeloma (PCM), which is characterized by the displacement of hematopoiesis and the formation of osteolytic bone lesions. The secreted glycoprotein Dickkopf-1 (DKK1), an inhibitor of the Wnt s... ...
